OF THE OUTREACH, RECRUITMENT AND EDUCATION CORE The Outreach, Recruitment and Education Core (Outreach Core) of the Yale ADRC will assist the Clinical Core in the recruitment of a clinical population, which will be accomplished through communication with the general public and health care professionals and service providers. Given that the Clinical Core will focus on the collection of biospecimens and other research materials from a subject population spanning the full continuum of Alzheimer's disease (AD) and other dementias, the Outreach Core will need to facilitate the recruitment of not only symptomatic patients, but also asymptomatic family members. Educational services will be provided to the public through a long-standing collaboration with the Alzheimer's Association, Connecticut Chapter. A key role of the Outreach Core will be to remove barriers to minority research participation and to extend education programs to a racially and ethnically diverse audience. Since scientific focuses of the Yale ADRC include cell biology, the integration of translational neuroscience, and biomarker studies, a particular educational need is in neuroscience education.
Aim 1 will assist the Clinical Core in the enrollment of approximately 500 subjects who will enter the Core Population for participation in research in five diagnostic categories on the full continuum of AD (from preclinical to dementia), as well as non-AD dementias and normal controls.
Aim 2 will provide educational services for the public about AD and related disorders.
Aim 3 will improve minority outreach and minority research participation. We will attain 18% minority participation commensurate with national demographics. A vital recent addition to this initiative is the Cultural Ambassadors program.
Aim 4 will improve educational services for health care professionals and service providers.
Aim 5 will enhance didactic and research training related to AD. An essential aim of the Outreach Core is to introduce new and future researchers at all levels to AD and the research opportunities available through the ADRC.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG047270-05
Application #
9728829
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
2021-05-31
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Meng, Jin; Ferguson, Shawn M (2018) GATOR1-dependent recruitment of FLCN-FNIP to lysosomes coordinates Rag GTPase heterodimer nucleotide status in response to amino acids. J Cell Biol 217:2765-2776
Nguyen, Andrew D; Nguyen, Thi A; Zhang, Jiasheng et al. (2018) Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay. Proc Natl Acad Sci U S A 115:E2849-E2858
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Scherer, Roberta W; Drye, Lea; Mintzer, Jacobo et al. (2018) The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials 19:46
Strittmatter, Stephen M (2018) Emerging Mechanisms in Alzheimer's Disease and Their Therapeutic Implications. Biol Psychiatry 83:298-299
Mecca, Adam P; Barcelos, Nicole M; Wang, Shuo et al. (2018) Cortical ?-amyloid burden, gray matter, and memory in adults at varying APOE ?4 risk for Alzheimer's disease. Neurobiol Aging 61:207-214
Gill, Thomas M; Han, Ling; Leo-Summers, Linda et al. (2018) Distressing Symptoms, Disability, and Hospice Services at the End of Life: Prospective Cohort Study. J Am Geriatr Soc 66:41-47
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161

Showing the most recent 10 out of 134 publications